BALB/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver

E Breous, S Somanathan, JM Wilson - Molecular Therapy, 2010 - cell.com
E Breous, S Somanathan, JM Wilson
Molecular Therapy, 2010cell.com
Following adeno-associated virus (AAV) gene transfer to the liver, both C57BL/6 and BALB/c
mice show long-term expression of nonself transgene antigens along with the absence of a
transgene-specific immune response. However, in this study, we report that despite the
equal ability to induce T-cell tolerance to vector-encoded antigens, the underlying
mechanisms are entirely different in these two strains. We have previously shown that in
C57BL/6 mice, cytotoxic T lymphocyte (CTL) responses to systemic AAV-delivered antigens …
Following adeno-associated virus (AAV) gene transfer to the liver, both C57BL/6 and BALB/c mice show long-term expression of nonself transgene antigens along with the absence of a transgene-specific immune response. However, in this study, we report that despite the equal ability to induce T-cell tolerance to vector-encoded antigens, the underlying mechanisms are entirely different in these two strains. We have previously shown that in C57BL/6 mice, cytotoxic T lymphocyte (CTL) responses to systemic AAV-delivered antigens are suppressed by combined actions of hepatic regulatory T cells (Tregs), Kupffer cells, and hepatic suppressive cytokines. In stark contrast, our present findings reveal that such tolerogenic response is not induced in the liver of BALB/c mice systemically administered with AAV. As a result, these mice fail to suppress a transgene-specific CTL response induced by a strong immunogenic challenge and express dramatically reduced levels of AAV-encoded antigen. Interestingly, there was active B-cell tolerance to the transgene antigen, which was mediated by splenic Tregs. We conclude that lack of tolerance induction in the liver renders BALB/c mice susceptible to CTL-mediated clearance of transduced hepatocytes.
cell.com